|
|
|
Volumn 164, Issue 7, 2001, Pages 1039-1041,-1043
|
|
Rofecoxib (Vioxx): a year in review.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ENZYME INHIBITOR;
LACTONE;
ROFECOXIB;
SULFONE;
ARTICLE;
CANADA;
CARDIOVASCULAR DISEASE;
CHEMICALLY INDUCED DISORDER;
DRUG SURVEILLANCE PROGRAM;
HUMAN;
KIDNEY DISEASE;
PAIN;
RISK FACTOR;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
CANADA;
CARDIOVASCULAR DISEASES;
ENZYME INHIBITORS;
HUMANS;
KIDNEY DISEASES;
LACTONES;
PAIN;
RISK FACTORS;
SULFONES;
|
|
EID: 0035799414
PISSN: 08203946
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
